Predict your next investment

Paradigm4 company logo
SOFTWARE (NON-INTERNET/MOBILE) | Database Management Software
paradigm4.com

See what CB Insights has to offer

Stage

Series A - II | Alive

Total Raised

$44.84M

Mosaic Score

+160 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Paradigm4

Paradigm4 is the developer of SciDB, a scalable, computational database management system designed for advanced analytics on multidimensional data. SciDB radically reduces the ask-to-answer loop-accelerating data-driven discovery.

Paradigm4 Headquarter Location

281 Winter Street Suite 360

Waltham, Massachusetts, 02451,

United States

Latest Paradigm4 News

New Products Posted to GenomeWeb: Thermo Fisher, Paradigm4, Applied Cells, More

Jul 23, 2021

Save for later Thermo Fisher Scientific Immune Repertoire Assays For Hemato-Oncology Research Thermo Fisher Scientific has launched a new suite of research-use-only Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T cells and B cells. Using Ion AmpliSeq technology, the new Oncomine pan-clonality assays target multiple parts of the B- and T-cell immune receptors using a single reaction with ultra-high sensitivity, increasing the probability of malignant clone detection and decreasing time to results. The new assays also overcome the challenge presented by current next-generation sequencing-based immune repertoire analysis of having to run multiple secondary tests due to the high test-failure rates, Thermo Fisher said. The assays uniquely target multiple parts of the receptor to reduce the need for secondary tests and increase the probability that a single assay can detect a potentially malignant clone. The new suite of immune repertoire assays are available on the Ion GeneStudio S5 System and feature integrated analysis and data visualization tools that simplify the interpretation of results for laboratories and healthcare professionals, the company said. Paradigm4 Reveal: Multi-Omics Paradigm4 has introduced Reveal: Multi-Omics, an app to help biopharmaceutical companies manage and analyze large sets of multiomic data. Reveal: Multi-Omics, built on top of the bioinformatics firm's  SciDB  database management platform, facilitates cross-study analyses and through rapid searches for genes and proteins across multiple public and proprietary datasets. The new app is an extension of Reveal, a translational informatics platform that Paradigm4 released in 2018. Applied Cells Mars Mag Cell Isolation Products Santa Clara, California-based Applied Cells has released its Mars Mag product line for applications on the company's Mars sample preparation and cell isolation platform. Mars Mag are flexible magnetic labeling products that can isolated a wide range of cell types with high purity, recovery, and reproducibility, the company said. They include Mars anti-phycoerythrin magnetic nanobeads that reduce per-experiment cost and enable flexible and easy protocols for capturing and purifying any subpopulation of PE-labelled cells, the company said. The products are intended to improve cell enrichment in tumor biology, genomics analysis, and cell therapeutic development. For more new products and services, please visit the New Products page on our website.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Paradigm4

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Paradigm4 in 1 CB Insights research brief, most recently on Nov 12, 2020.

Expert Collections containing Paradigm4

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Paradigm4 is included in 1 Expert Collection, including Omics.

O

Omics

975 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Paradigm4 Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Paradigm4 Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.